---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-228161"
form_type: "8-K"
ticker: "AMGN"
cik: "0000318154"
company_name: "AMGEN INC"
filed_at: "2023-09-05T23:59:59+00:00"
generated_at: "2026-06-11T00:14:55.442667+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Amgen clears FTC hurdle for Horizon acquisition; Irish court hearing Oct 5

## Summary
- US District Court dismissed preliminary injunction motion and dissolved TRO on Sept 1, 2023.
- FTC administrative lawsuit against Amgen and Horizon ended after consent order agreement.
- Irish High Court set Oct 5, 2023 hearing to consider Horizon's scheme of arrangement sanction.
- Acquisition of Horizon moves toward close pending Irish court approval and other conditions.

## SEC filing metadata
- accession: 0001193125-23-228161
- form_type: 8-K
- ticker: AMGN
- cik: 0000318154
- company_name: AMGEN INC
- filed_at: 2023-09-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318154/000119312523228161/0001193125-23-228161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318154/000119312523228161/d449681d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-228161
- JSON: https://secwatch.observer/filing/0001193125-23-228161.json
- Plain text: https://secwatch.observer/filing/0001193125-23-228161.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.